| 【Sector Research】China CIS Sector – Can non-mobile CIS strength offset handset weakness? We remain cautiously optimistic |
| 【Company Research】China Meidong Auto (1268 HK) – Resilient amid tough macro after in-line FY21 |
| 【Company Research】Jinxin Fertility (1951 HK) – Strengthen leading positioning in ARS industry |
| 【Company Research】Haier Smart Home (6690 HK) – Still the outperformer in a tough market |
| 【Company Research】Mengniu (2319 HK) – Raw milk price remained a lingering drag to 2H21 GPM; 2022E guidance maintained |
| 【Sector Research】China Software & IT Services – Diverging property SaaS outlook |
| 【Company Research】Shengyi Technology (600183 CH) – Headwinds to persist into 1H22; Maintain HOLD |
| 【Fixed Income Research】COGARD - Prudently navigating through the storm |
| 【Company Research】I-Mab BioPharma (IMAB US) – Lemzoparlimab showed encouraging data on MDS |
| 【Company Research】Innovent Biologics (1801 HK) – Expanding portfolio of commercial products |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
